The FDA has authorized additional omicron bivalent booster doses for people 65 and older and those with compromised immune systems, the agency said April 18.
Read the full post on Becker's Hospital Review - Healthcare News
FDA authorizes additional booster for high-risk individuals, rescinds monovalent shots
